Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adaptive Biotechnologies Corp Director's Dealing 2025

Mar 13, 2025

31660_dirs_2025-03-12_a96ec0be-3b45-4a7a-97d3-e56e50668bd9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2025-03-12

Reporting Person: HERSHBERG ROBERT (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-12 Common Stock S 53000 $7.59 Disposed 69690 Direct